Top Markets
#1 OVERTAKE OVERTAKE +74.18%
#2 Clearpool Clearpool +29.60%
#3 Playnance Playnance +28.17%
#4 Concordium Concordium +23.87%
#5 Nillion Nillion +19.42%
#6 B3 (Base) B3 (Base) +18.55%
#7 deBridge deBridge +17.19%
#8 龙虾 (Lobster) 龙虾 (Lobster) +14.40%
#9 Codatta Codatta +14.22%
#10 Raydium Raydium +13.19%
Coin of the day
OVERTAKE OVERTAKE
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Rangering i aksjer #23
Johnson & Johnson is a holding company, which engages in the research,... Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Aksjekurs
$267.84
Markedsverdi
$645.47B
Endring (1 dag)
-0.63%
Endring (1 år)
51.68%
Land
US
Handel Johnson & Johnson (JNJ)

Kategori

Healthcare
Antall utestående aksjer for Johnson & Johnson (JNJ)
Antall utestående aksjer per June 2026: 2.44B
Ifølge Johnson & Johnson sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 2.44B. Ved slutten av December 2024 hadde selskapet 2.41B utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Johnson & Johnson (JNJ) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 2.44B 0.48%
2025 2.43B 0.88%
2024 2.41B -4.98%
2023 2.53B -3.63%
2022 2.63B -0.13%
2021 2.63B 0.00%
2019 2.63B -1.12%
2018 2.66B -0.75%
2017 2.68B -0.89%
2016 2.71B -1.77%
2015 2.76B -1.01%
2014 2.78B -1.33%
2013 2.82B 1.52%
2012 2.78B 1.99%
2011 2.72B -0.50%
2010 2.74B -0.79%
2009 2.76B -1.85%
2008 2.81B -2.46%
2007 2.88B -1.93%
2006 2.94B -1.23%
2005 2.98B 0.28%
2004 2.97B 0.00%
2003 2.97B -1.02%
2002 3.00B -1.07%
2001 3.03B 1.25%
2000 2.99B 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 892.40M -63.43%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 1.77B -27.42%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 796.00M -67.38%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 0.00 -100.00%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
 1.91B -21.60%
CH